Group One Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Group One Trading’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,898	Closed	-$594K	–	8352
2024 Q4	$466K	Buy	12,898 +9,782	+314%	+$342K	﹤0.01%	3228
2024 Q3	$99.8K	Sell	3,116 -1,460	-32%	-$54.5K	﹤0.01%	4174
2024 Q2	$172K	Sell	4,576 -11,547	-72%	-$486K	﹤0.01%	3525
2024 Q1	$794K	Buy	16,123 +15,709	+3,794%	+$726K	﹤0.01%	2295
2023 Q4	$15.1K	Buy	+414	New	+$10.8K	﹤0.01%	5944
2023 Q3	–	Sell	-1,316	Closed	-$36K	–	8282
2023 Q2	$34.5K	Buy	+1,316	New	+$34.6K	﹤0.01%	5572
2022 Q3	–	Sell	-3,014	Closed	-$86.4K	–	8234
2022 Q2	$74K	Buy	+3,014	New	+$110K	﹤0.01%	5242

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Group One Trading's SWTX Position: Q1 2025 in Review

Group One Trading sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 12,898 shares — an estimated $594K sold.

Group One Trading first reported a position in SWTX in Q2 2022 and held it in 7 quarters. The position peaked at $794K in Q1 2024. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

Group One Trading reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
Group One Trading sold 12,898 SpringWorks Therapeutics shares in Q1 2025, an estimated $594K.
Group One Trading first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 7 quarters.
Group One Trading's SpringWorks Therapeutics position peaked at $794K in Q1 2024.
306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.